130 likes | 415 Views
Department of Gastroenterology, Hepatology, and Nutrition ... At least 12 weeks or more, which need not be. consecutive, in the preceding 12 months, of ...
E N D
1. Overview ofIrritable Bowel Syndrome Arnold Wald, MD
Professor of MedicineDepartment of Gastroenterology, Hepatology, and NutritionUniversity of Pittsburgh Medical Center
Pittsburgh, Pennsylvania
2. Chronic or recurrent GI symptoms
Lower abdominal pain/discomfort
Altered bowel habits
Bloating
Not explained by structural or biochemical abnormalities
3. IBS Clinical Subgroups Constipation predominant
Diarrhea predominant
Alternating constipation/diarrhea
4. IBS Clinical Subgroups Constipation predominant
Diarrhea predominant
Alternating constipation/diarrhea
5. Rome II Criteria for IBS At least 12 weeks or more, which need not be
consecutive, in the preceding 12 months, of
abdominal discomfort or pain that has 2 out
of 3 features:
Relieved by defecation
Onset associated with a change in frequency of stool
Onset associated with a change in form (appearance) of stool
6. Epidemiology of IBS in US(15% to 20% of Population)
7. Prevalence of Disorders in US IBS: 15% - 20%
Dyspepsia: 8%
GE reflux: 7%
Asthma: 4%
Diabetes: 3%
8. IBS Symptoms Reduce Patient Well Being
9. Medical Costs Associated With IBS Estimated $8 billion annually in direct costs
Increased physician visits for both GI and non-GI complaints
IBS patients incur 74% more health care costs than do non-IBS sufferers
10. Impact of IBS on Work Missed work: 30% (1.7 days)
Reduced days: 46% (3 days)
Turned down promotion: 16%
Changed job, health reasons: 9%
Changed work schedule: 8%
11. Pathophysiology of IBS: A Biopsychosocial Disorder Biological
Altered GI motor activity
Altered visceral sensation
Psychosocial
Behavioral
Cognitive
Emotional
12. Multiple Medications Are Used to Treat IBS Anticholinergics
Tricyclic antidepressants
SSRIs
Antidiarrheals
Bulking agents
Laxatives
Alosetron*
13. New Treatment Paradigm for C-IBS